• All
  • Important
  • Financial Update
  • Fund Raise
  • Board Meeting
  • Dividend/Bonus
  • JV/Acquisition
  • Investor Meet
  • Insider Trade
  • Pledging
  • Others
    ALPHA TRIBE

    Gland Pharma Limited — Board Meeting, 28-01-2026: Outcome of Board Meeting

    28-01-2026 | 05:10 pm

    Gland Pharma's Board approved strong Q3 FY26 consolidated results: Revenue up 22% YoY to ₹1,695.4 Cr, and Adj. PAT surged 37% to ₹279.7 Cr. Growth was fueled by new product launches, CDMO ramp-ups, and Cenexi's improved performance. R&D investments increased.

    No comments yet. Be the first to comment!

    All announcements from Gland Pharma Limited